glp1.how

reference

Eli Lilly

Updated Jul 14, 2026

Eli Lilly and Company is a U.S.-based pharmaceutical manufacturer and one of the two dominant makers of GLP-1-class medications, alongside Novo Nordisk. Lilly manufactures tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight management. The company also runs LillyDirect, a direct-to-patient platform offering access to its medications and savings programs.